MODULE 6 MEDICATIONS Flashcards
(32 cards)
1
Q
ACTIVATED CHARCOAL
CLASSIFICATION
A
- ANTIDOTE
- ADSORBANT AGENT
2
Q
ACTIVATED CHARCOAL
DOSE
A
- 25 - 50 G PO/NG
3
Q
ACTIVATED CHARCOAL
INDICATION
A
- SUSPECTED OVERDOSE
4
Q
ACTIVATED CHARCOAL
CONTRAINDICATION
A
- NO GAG REFLEX
- TCA OVERDOSE
- CAUSTIC SUBSTANCES
5
Q
ACTIVATED CHARCOAL
ADVERSE EFFECTS
A
- CONSTIPATION
- ASPIRATION
- DIARRHEA
- NAUSEA
- VOMITTING
6
Q
ETOMIDATE
CLASSIFICATION
A
- SEDATIVE HYPNOTIC
7
Q
ETOMIDATE
DOSE
A
- 0.3 MG/KG IV/IO OVER 30
8
Q
ETOMIDATE
INDICATION
A
- RSI
- SEDATION
9
Q
ETOMIDATE
CONTRAINDICATION
A
- HYPERSENSITIVITY
10
Q
ETOMIDATE
ADVERSE EFFECTS
A
- RESPIRATORY DEPRESSION
- PAIN UPON INJECTION
- LOCK JAW
- NAUSEA
- VOMITTING
11
Q
KETAMINE
CLASSIFICATION
A
- NON-BARBITUATE ANESTHETIC (DISSOCIATIVE)
12
Q
KETAMINE
DOSAGE (RSI)
A
- 1 - 2 MG/KG IV/IO
- 3 - 4 MG/KG IM
13
Q
KETAMINE
DOSAGE (PAIN MANAGMENT)
A
- 5 - 20 MG IV
- 25 - 50 MG IM
- 20 - 40 MG IN
14
Q
KETAMINE
DOSAGE (PEDIATRIC)
A
- 0.05 - 0.2 MG/KG IV
- 0.25 - 0.75 MG/KG IM
- 0.2 - 0.4 MG/KG IN
15
Q
KETAMINE
INDICATION
A
- RSI
- EXCITED DELIERIUM
- PAIN MANAGMENT
- DISLOCATION REDUCTION
16
Q
KETAMINE
CONTRAINDICATION
A
- LESS THAN 3 MONTHS OF AGE
- SCHIZOPHRENIC EPISODES
- PREGNANCY
17
Q
KETAMINE
ADVERSE EFFECTS
A
- INCREASED ICP
- EXTRAPYRAMIDAL SYMPTOMS
- RASH
- NEASEA
- VOMITTING
- DROWINESS
- BRONCHIAL SECREATIONS
- CATECOLAMINE RELEASE
18
Q
SUCCINYLCHOLINE
CLASSIFICATION
A
- NEUROMUSCULAR BLOCKING AGENT
19
Q
SUCCINYLCHOLINE
DOSE
A
1-2 MG/KG IV/IO
(PEDI & ADULT)
20
Q
SUCCINYLCHOLINE
INDICATION
A
- RSI
21
Q
SUCCINYLCHOLINE
CONTRAINDICATION
A
- CONDITIONS THAT MAY CAUSE HYPERKALEMIA
- NEUOMUSCULAR DISEASE
- RENAL FAILURE
- INABILITY TO BVM
- RHABDOMYOLITIS
- MALIGNANT HYPRETHERMIA
22
Q
SUCCINYLCHOLINE
ADVERSE EFFECTS
A
- BRADYCARDIA
- PRESSOR RESPONSE
23
Q
TRANEXAMIC ACID (TXA)
CLASSIFICATION
A
- ANTI-FIBROLYTIC
24
Q
TRANEXAMIC ACID (TXA)
DOSE
A
- 1-2 G IN 100 CC NS OVER 10
25
TRANEXAMIC ACID (TXA)
| INDICATION
* TRAUMATIC HEMMORAGIC SHOCK
26
TRANEXAMIC ACID (TXA)
| CONTRAINDICATION
* SIGNIFIGANT CLOSED HEAD INJURY
27
TRANEXAMIC ACID (TXA)
| ADVERSE EFFECTS
* VISUAL DISTURBANCES
* DVT
* THROMBOSIS
* NEASUA
* VOMITING
* DIARRHEA
28
VERCURONIUM
| CLASSIFICATION
* NEUROMUSCULAR BLOCKING AGENT
29
VERCURONIUM
| DOSE
0.15 MG/KG IV/IO (INITIAL PARALYIS)
0.05 - 0.1 MG/KG IV/IO
30
VERCURONIUM
| INDICATION
31
VERCURONIUM
| CONTRAINDICATION
32
VERCURONIUM
| ADVERSE REACTION